U.S. Mortgage REITs Stock News

The Trump administration’s decision to make tariffs permanent on 99.4% of U.S. imports and introduce new 10% to 12.5% rates on goods from 60 countries could reshape where risks and opportunities sit in your portfolio. For investors who prefer smaller U.S. stocks with value traits, this backdrop may put more attention on companies that are priced modestly, pay dividends, and are less tied to global supply chains. This article looks at 3 small-cap value stocks from our screener that appear...

Alphatec Holdings stock has fallen about 60.2% year to date, yet its valuation checks still lean towards the shares looking cheap on several measures. This sets up a clear tension between weak price performance and a relatively supportive valuation profile. Year to date, the share price is down 60.2%, which signals that sentiment around Alphatec Holdings has been under pressure for an extended period. Expectations for the company’s ability to grow its spine surgery business can support the...

Diamondback Energy has delivered a powerful run over the last five years, yet the valuation checks now suggest the stock looks closer to fairly priced than clearly cheap. Diamondback Energy has returned 228.0% over five years, which puts more pressure on today’s buyers to judge whether that kind of performance already reflects much of the good news. Expectations for strong production and cash generation from core Permian Basin assets can support the current share price. However, any setback...

Pathward Financial (CASH) has updated its outlook, raising fiscal 2026 earnings guidance to an EPS range of $7.80 to $8.20 and introducing 2027 guidance of $9.50 to $10.00. See our latest analysis for Pathward Financial. Pathward Financial's latest guidance and ongoing share repurchases come after a mixed price pattern, with the share price rising 19.52% year to date but easing over the past quarter, while 3 year and 5 year total shareholder returns of 62.67% and 75.98% point to momentum...

Corcept Therapeutics (CORT) is back in focus after the FDA approved Lifyorli, its relacorilant combination for platinum resistant ovarian cancer. This development broadens revenue sources beyond flagship drug Korlym. See our latest analysis for Corcept Therapeutics. Corcept Therapeutics has seen strong share price momentum, with a 30 day share price return of 16.92% and a 90 day share price return of 107.03%. The 1 year total shareholder return of 39.64% and 5 year total shareholder return of...

Peabody Energy (BTU) is back in focus after multiple law firms launched class action lawsuits tied to alleged misstatements about production growth at its Centurion mine and subsequent reduced operational guidance. See our latest analysis for Peabody Energy. The class action headlines arrive after a period where Peabody Energy’s share price return has fallen 14.29% over 90 days and 25.68% year to date to US$22.80, even though the 1 year total shareholder return is 38.17% and the 5 year total...

Why Intuit’s Legal and Business Shifts Matter for Shareholders Intuit (INTU) is under pressure after a class action lawsuit, a cut to its TurboTax fiscal 2026 revenue outlook, and sizable job reductions. These developments have sharpened focus on the stock’s risk profile. See our latest analysis for Intuit. These legal and business updates come after a sharp reset in sentiment around Intuit, with a 30 day share price return of 13% contrasting with a year to date share price decline of 52.92%...

Earlier this week, Cabot Corporation received an upgrade from Zacks to a Rank #2 (Buy), reflecting increased optimism around its earnings outlook and improved estimate revisions. This shift in analyst sentiment suggests that Cabot's underlying business trends are being viewed more favorably, potentially reinforcing confidence in its longer-term earnings profile. Next, we’ll examine how this improved earnings outlook, as flagged by the Zacks upgrade, interacts with Cabot’s existing investment...

Earlier this week, UiPath came under pressure after OpenAI released its Presence AI agent deployment platform, raising worries about intensified competition in enterprise automation. The comparison has highlighted how UiPath’s Maestro platform differs by coordinating both AI agents and software bots while remaining model-agnostic, which may matter more than headline competition alone. Next, we’ll explore how concerns around OpenAI Presence’s competitive threat could influence UiPath’s...

Old National Bancorp (ONB) drew fresh investor attention after reporting second quarter 2026 results, with higher net income, stronger net interest income and modest net charge offs, alongside ongoing share repurchases. See our latest analysis for Old National Bancorp. At a share price of $26.49, Old National Bancorp has seen stronger momentum build recently, with a 30 day share price return of 3.27% and a 90 day gain of 13.40%. This sits alongside a 1 year total shareholder return of 25.40%...

Del Monte (DMC) has expanded its senior unsecured revolving credit facility to $900 million while keeping the existing 2029 maturity. The move is tied to funding a recent acquisition and seasonal working capital. See our latest analysis for Del Monte. The recent amendment to Del Monte's revolving credit facility comes after a weak 90 day share price return, with the stock down 32.35% and the year to date share price return down 19.85%. However, the 3 year total shareholder return remains...

Lattice Semiconductor (LSCC) is back in focus after reporting better than expected results and issuing stronger guidance, alongside a planned $1b acquisition of AMI to expand its data center and firmware capabilities. See our latest analysis for Lattice Semiconductor. Lattice Semiconductor’s latest guidance and the planned AMI acquisition come after a sharp pullback, with the share price down 7.03% on the day and 10.78% over 30 days. This comes alongside a 63.28% year to date share price...

Earlier in July 2026, TD SYNNEX announced it had been named one of Fortinet’s approved global distributors, while Fortinet also unveiled new AI-focused FortiEndpoint capabilities aimed at governing AI usage, protecting sensitive data, and simplifying security operations across distributed environments. Together, the expanded TD SYNNEX relationship and AI-enhanced FortiEndpoint platform underline how Fortinet is tying wider global reach to deeper, AI-centric security integration across its...

SLB stock has more than doubled over the past five years, and the latest Discounted Cash Flow (DCF) work still points to an intrinsic value comfortably above the current share price, even as broader valuation checks come through with a more mixed message. SLB has returned 102.9% over the last five years, so current holders are sitting on sizeable gains that put more focus on whether the share price still lines up with fundamentals. Growth potential from subsea contracts and AI focused data...

Jabil stock has delivered very strong long term returns, yet at a last close of US$312.59 the company still screens as materially undervalued on both its Discounted Cash Flow (DCF) intrinsic value estimate and market based multiples. Over the past 5 years, Jabil has returned 433.5%, which puts extra focus on whether the current share price still leaves a margin between market price and underlying value. Recent moves to expand AI enabled logistics capacity in Penang and a sizable share...

Patterson-UTI Energy, Inc. recently prepared to report its second-quarter 2026 results, with consensus pointing to a 3 cents per share loss on expected revenues of US$1.15 billion amid pressure across its Drilling Services, Completion Services, and Drilling Products segments and higher operating costs. At the same time, the company’s longer-term profile of annual revenue growth, large US$4.66 billion scale, and improving EBITDA efficiency has kept attention on how its cost structure and...

AMETEK stock has delivered a strong 79.8% return over the past five years, yet current valuation checks, including an intrinsic value estimate based on a Discounted Cash Flow (DCF) model and market multiples, both point to the shares trading at a premium rather than offering clear value. The 79.8% five year return highlights that long term holders have already captured a substantial gain. This can reduce the margin of safety for new investors if fundamentals do not keep pace. Expectations...

Automatic Data Processing (ADP) is back in focus as investors react to projections ahead of its upcoming earnings report, with Wall Street expecting higher earnings per share, revenue and Employer Services segment contribution. See our latest analysis for Automatic Data Processing. Automatic Data Processing's recent 13.75% 1 month share price return and 27.25% 3 month share price return point to building momentum into the earnings release, although the 1 year total shareholder return declined...

Twist Bioscience stock has delivered a very strong 261.2% return over the past 3 years, yet the broader valuation checks point to a company that currently appears expensive rather than obviously cheap. That tension between a powerful share price run and a low value score is what investors now have to weigh. Twist Bioscience's 261.2% return over 3 years highlights how much optimism is already reflected in the share price. Expectations around the company turning its science into durable...

Earlier this month, BrightSpring Health Services was moved from the S&P 600 to the S&P 400 and S&P 400 Health Care indices, reflecting its reclassification within the US mid‑cap universe. This index shift, coinciding with strong quarterly results and revenue growth ahead of healthcare peers, has increased the company’s visibility among institutional investors and index‑tracking funds. We’ll now explore how BrightSpring’s move into the S&P 400, alongside its recent operating performance, may...

The Trade Desk (TTD) is in focus after announcing a new integration that lets advertisers tap SEVEN-ELEVEN JAPAN retail purchase data across its platform, marking a material shift for data-driven campaigns in Japan. See our latest analysis for Trade Desk. For context, Trade Desk’s 1 day share price return of 2.98% comes after a weak run, with the 90 day share price return down 27.87% and the 1 year total shareholder return down 79.93%, which points to fading momentum despite a busy period of...

With the average 30 year mortgage rate at 6.58% and the 10 year Treasury yield at 4.7%, banks and mortgage lenders are sitting at the center of some powerful cross currents in borrowing costs, inflation expectations and housing activity. Higher rates can reshape profit pools, squeeze some business lines and open opportunities in others. This article breaks down how that rate backdrop and the recent conflict driven move in oil prices tie into the Financial Sector, Banks and Mortgage Lenders...

Delays at the Rosebank oilfield, now expected to push first production to at least 2027, have put a spotlight on stocks tied to North Sea projects. When equipment is stuck on the seabed and rigs are idle for months, project cash flows and investor expectations can quickly shift. This article looks at how that kind of disruption, along with uncertain UK government decisions on future North Sea drilling, may pressure companies closely linked to offshore development. It will walk through 3...

Stryker (SYK) is drawing fresh attention after launching its Mako RPS handheld robotic system in the U.S. for total knee replacements, extending the Mako portfolio beyond traditional robotic arm platforms. See our latest analysis for Stryker. The Mako RPS launch comes as Stryker’s share price has recently picked up, with a 1 day share price return of 3.54% and a 30 day share price return of 5.28%, even though the year to date share price return is down 5.15% and the 1 year total shareholder...